salvin has been researched along with vitamin d 2 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duggal, J; Harrison, JS; Studzinski, GP; Wang, X | 1 |
| Harrison, JS; Studzinski, GP; Wang, X | 2 |
| Danilenko, M; Kutner, A; Nachliely, M; Sharony, E | 1 |
| Bolla, NR; Danilenko, M; Kutner, A; Nachliely, M; Sharony, E | 1 |
| Danilenko, M; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X | 1 |
| Danilenko, M; Dawod, A; Harrison, JS; Nachliely, M; Studzinski, GP; Wang, X | 1 |
| Liu, C; Luna, A; Pham, K; Studzinski, GP; Wang, X; Wu, Q | 1 |
8 other study(ies) available for salvin and vitamin d 2
| Article | Year |
|---|---|
Involvement of microRNA181a in differentiation and cell cycle arrest induced by a plant-derived antioxidant carnosic acid and vitamin D analog doxercalciferol in human leukemia cells.
Topics: Abietanes; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Cell Cycle Checkpoints; Cell Differentiation; Drug Synergism; Ergocalciferols; Gene Expression Regulation, Neoplastic; HL-60 Cells; Humans; Leukemia; MicroRNAs; Plant Extracts; U937 Cells; Vitamins | 2012 |
Enhancement of arabinocytosine (AraC) toxicity to AML cells by a differentiation agent combination.
Topics: Abietanes; Annexin A5; Antimetabolites, Antineoplastic; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Cycle Proteins; Cell Differentiation; Comet Assay; Cytarabine; DNA Damage; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Phosphorylation; Propidium; U937 Cells | 2016 |
Novel analogs of 1,25-dihydroxyvitamin D
Topics: Abietanes; Antineoplastic Agents; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Screening Assays, Antitumor; Ergocalciferols; Genes, Reporter; Humans; Leukemia, Myeloid, Acute; Point Mutation; Polyphenols; Receptors, Calcitriol; Transcriptional Activation | 2016 |
The role of VDR and BIM in potentiation of cytarabine-induced cell death in human AML blasts.
Topics: Abietanes; Adult; Aged; Aged, 80 and over; Apoptosis; Bcl-2-Like Protein 11; Cytarabine; Drug Synergism; Ergocalciferols; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Receptors, Calcitriol; RNA Interference; Tumor Cells, Cultured; U937 Cells | 2016 |
Prodifferentiation Activity of Novel Vitamin Dâ‚‚ Analogs PRI-1916 and PRI-1917 and Their Combinations with a Plant Polyphenol in Acute Myeloid Leukemia Cells.
Topics: Abietanes; Cell Differentiation; Cell Line, Tumor; Ergocalciferols; G1 Phase Cell Cycle Checkpoints; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Plant Extracts; Polyphenols | 2016 |
Participation of vitamin D-upregulated protein 1 (TXNIP)-ASK1-JNK1 signalosome in the enhancement of AML cell death by a post-cytotoxic differentiation regimen.
Topics: Abietanes; Antineoplastic Agents; Antioxidants; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cytarabine; Ergocalciferols; Humans; Leukemia, Myeloid, Acute; MAP Kinase Kinase Kinase 5; Mitogen-Activated Protein Kinase 8; Signal Transduction; Vitamins | 2019 |
Differentiation agents increase the potential AraC therapy of AML by reactivating cell death pathways without enhancing ROS generation.
Topics: Abietanes; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cytarabine; Ergocalciferols; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Reactive Oxygen Species; Receptors, Calcitriol; RNA Interference; RNA, Small Interfering; U937 Cells; Vitamin D | 2020 |
Enhancement of sorafenib-mediated death of Hepatocellular carcinoma cells by Carnosic acid and Vitamin D2 analog combination.
Topics: Abietanes; Antineoplastic Agents; Antioxidants; Apoptosis; Autophagy; Bone Density Conservation Agents; Carcinoma, Hepatocellular; Cell Proliferation; Drug Synergism; Drug Therapy, Combination; Ergocalciferols; Humans; Liver Neoplasms; Signal Transduction; Sorafenib; Tumor Cells, Cultured | 2020 |